# Bortezomib

NDC: 68083-650
Generic name: Bortezomib
Labeler / Manufacturer: Gland Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20260106

FDA application: ANDA219167

## Active ingredients

- BORTEZOMIB: 1 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68083-650"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68083-650
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd698074-da21-4b53-8f6b-241535a8d598